Kidney International Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2025-02-06 白衣13 来自新南威尔士

1.30 投稿
1.31改格式
2.6分配ME，under review
不确定是内审还是外审

23 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-11-04 ms1469747388241577 来自辽宁省

投稿一个月被拒，压根没送外审，内审一个月，耽误事

54 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-10-25 ms7000001839177437 来自重庆

同样是under review，已经5天了

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-08-19 ms7000000034057106 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肾脏病
经验分享：还行

58 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-07-27 没证的蒲肯野来自浙江省

投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭

130 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-10-14 xc494192838

几个小时就under review不知道是不是只是内审而非外审

157 14 举报

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-06-28 MsyR 来自山东省

刚投完一个original article，稿件编号700多

100 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-03-21 ms4000000293208382 来自山东省

这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊

83 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-03-21 ms4000000293208382 来自山东省

这个期刊还要求共享数据吗？

84 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2250700, encodeId=3a122250e006d, content=1.30 投稿 1.31改格式 2.6分配ME，under review 不确定是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Feb 06 09:54:35 CST 2025, time=2025-02-06, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2235157, encodeId=45f3223515ec8, content=投稿一个月被拒，压根没送外审，内审一个月，耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Mon Nov 04 22:01:02 CST 2024, time=2024-11-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2233081, encodeId=4086223308190, content=同样是under review，已经5天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86039197407, createdName=ms7000001839177437, createdTime=Fri Oct 25 11:47:10 CST 2024, time=2024-10-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 Mia

推荐同行评议时需要注意哪些情况？

190 2 举报

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务